# Visit Brief + Independent Clinical Inbox — received R2 PASS checkpoint

> **DATE CHECKPOINTED:** 2026-10-08 Asia/Nicosia.
> **SOURCE:** independent R2 handback supplied by the Product Owner after the 2026-10-07 review.
> **STATUS:** DURABLE RECEIPT OF PRIOR REVIEW RESULT; not a new review and not implementation authority.
> **TARGET REVIEWED:** branch `docs/cockpit-visit-brief-clinical-inbox-2026-10-07` at `6ccc7b5d1cc9e5d53a50cdccf34c57e30ea7ad45`; design-bearing head `e305a9678183cab84df7825a4f59c5d4a841e113`.
> **DESIGN BLOB:** `8ee79a96350f9ac42059eeb2a3e836cbe9d11245`.
> **REVIEW REQUEST BLOB:** `5bb6de5fce76170ca65d0422a4d6ed8272aabc20`.

## Received verdict

```text
PASS / COMPLETE_FOR_DECLARED_SCOPE
P0:P1:P2 = 0:0:0
```

The independent handback reported no material blocker within the declared Q1–Q6 scope.

Received dispositions:
- Q1 two independent entrances / one clinical-attention lifecycle — PASS.
- Q2 always-on Gmail intake / free-service sleep / freshness — PASS, activation gates open.
- Q3 patient identity / contact authority / invalidation — PASS.
- Q4 source semantics / candidate vs authoritative result — PASS.
- Q5 clinician-approved Reception → Zadarma / callback rules — PASS, provider qualification open.
- Q6 privacy / retention / failure / first-code eligibility — PASS, mandatory pre-code/live gates remain.

The reviewer identified the narrowest later first-code boundary as A only:

> shared `ClinicalAttentionItem` core + both UI entrances using synthetic/manual typed sources + protected existing patient/G3 reads, with no Gmail provider effect, no Zadarma effect and no authoritative result acceptance.

Before persistent A, the review required freezing the minimal persistent contracts for fields/link/candidate, version/conflict, access/auth and retention/deletion.

The handback explicitly granted no implementation, merge, deploy, OAuth, Gmail, Zadarma, Reception mutation, Calendar mutation, booking or patient-data authority.

## Relationship to the 2026-10-08 Visit Capture delta

This receipt closes only the prior Q1–Q6 scope. A new material behavior was subsequently clarified by the Product Owner:

```text
Heidi today + GESY today + previous GESY
→ Dia browser candidate insertion
→ Cockpit clinician review
→ one Save
→ protected encounter
```

That new clinical write boundary is therefore handled by the separate bounded delta:
`cockpit/VISIT_CAPTURE_DIA_HEIDI_GESY_DELTA_2026-10-08.md`.

Do not reopen the prior Q1–Q6 review merely because the delta exists. Review only direct contradictions/affected cumulative seams.
